Dianthus Therapeutics | MGTA - EPS Earnings Per Share

Stock Price
48.13
Daily Change
-4.33 -8.25%
Monthly
30.47%
Yearly
94.62%
Q1 Forecast
51.75

Dianthus Therapeutics reported $-0.97 in EPS Earnings Per Share for its fiscal quarter ending in September of 2025.





Eps Change Date
Alaunos Therapeutics USD -0.53 0.07 Sep/2025
Avita Medical AUD -0.38 0.16 Jun/2025
Celltrion KRW 1.13K 317.83 Sep/2025
Cspc Pharmaceutical CNY 0.08 0.01 Sep/2025
Dianthus Therapeutics USD -0.97 0.09 Sep/2025
Divis Laboratories Ltd INR 25.97 5.48 Sep/2025
IQVIA Holdings USD 3 0.19 Sep/2025
Kangmei Pharma CNY 0 0 Sep/2025
Knight Therapeutics CAD -0.03 0.07 Jun/2025
Laboratorios Farma EUR 1.96 0.71 Dec/2023
Malin Corporation EUR 0 0 Dec/2024
Medical Developments International AUD 0 0 Jun/2025
Moderna USD -0.51 1.62 Sep/2025
Neuren Pharmaceuticals AUD 0.06 0.97 Jun/2025
Organigram Holdings CAD -0.18 0.13 Sep/2025
Organon & Co USD 1.01 0.01 Sep/2025
Pharma Mar EUR -0.23 1.55 Sep/2025
Qiagen NV USD 0.53 0.07 Sep/2025
Revvity USD 1.7 0.52 Dec/2025
Sartorius EUR 1.26 0.63 Dec/2025
Sino Biopharmaceutical CNY 0.16 0.07 Jun/2025
Tectonic Therapeutic USD -1.02 0.05 Sep/2025
Tilray USD -0.41 0.4 Dec/2025
Viatris USD 0.67 0.05 Sep/2025
Xeris Pharmaceuticals USD 0 0.02 Sep/2025
Zhangzhou Pientzehuang Pharmaceutical CNY 1.53 0.8 Sep/2025